Real-time enrollment status for this non small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:02 PM UTC
| NCT Number | NCT06150664 |
| Recruiting Status | Recruiting |
| Condition | Non Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 85 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Compass Therapeutics |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of October 12, 2026: Clinical trial NCT06150664 is currently recruiting participants. This phase1 study for non small cell lung cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Compass Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06150664 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06150664 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.